Existing ingestible electronics represent a trillion-dollar market. Yet, they suffer from retention risk as they use non-degradable and potentially toxic materials therefore cannot be used at the point-of-care.
EDISENS will work towards “edible microelectrofluidic biosensors”, i.e. biosensors that the human body can digest after completing its task, by employing food-derived materials with the aim of producing diagnostic food capable of measuring diagnostically relevant parameters.
EDISENS works toward the vision that clinical testing will be as easy as eating candy one day.